SciELO - Scientific Electronic Library Online

 
vol.44 issue2Survival and prognostic factors of patients with clinically localized prostate cancerDental health policies in Brazil and their impact on health inequalities author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista de Saúde Pública

Print version ISSN 0034-8910

Abstract

MORAES, José Cássio de; LUNA, Expedito José de Albuquerque  and  GRIMALDI, Rosária Amélia. Immunogenicity of the Brazilian hepatitis B vaccine in adults. Rev. Saúde Pública [online]. 2010, vol.44, n.2, pp.353-359. ISSN 0034-8910.  http://dx.doi.org/10.1590/S0034-89102010000200017.

OBJECTIVE: To evaluate the immunogenicity and safety of a novel hepatitis B vaccine, after increasing antigen concentration to 25 μg, in comparison to the reference vaccine. METHODS: Single-blinded randomized trial comparing VrHB-IB (Instituto Butantan) and the reference vaccine (Engerix B®, Glaxo Smith Kline). Volunteers aged 31 to 40 years were randomized to either experimental (n=216) or control (n=203) groups, and were given three doses of vaccine. The first dose was administered upon recruitment, and the second and third doses 30 and 180 days later, respectively, between 2004 and 2005. Blood samples were collected for analysis before randomization and after the second and third doses. Active search for adverse effects was perforned in the first five days after vaccination. Differences were evaluated using chi-square and Fisher's exact tests, with a 5% significance level. RESULTS: No severe adverse effects were observed. Seroprotection was confirmed in 98.6% (213/216) of volunteers in the experimental group and 95.6% (194/203) of those in the control group. Geometric mean titers were 12,557 and 11,673, respectively. CONCLUSIONS: The Brazilian vaccine was considered to be equivalent to the reference vaccine and its use is recommended for adults.

Keywords : Hepatitis B Vaccines; Efficacy; Hepatitis B [prevention & control]; Controlled Clinical Trial.

        · abstract in Portuguese | Spanish     · text in English | Portuguese     · English ( pdf ) | Portuguese ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License